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Abstract Since 1999, attempts have been made in the application of a new technique called 
magnetic seizure therapy (MST) or magnetic convulsion therapy (MCT) in the 
treatment of depressive disorder – as an alternative to electroconvulsive treatment. 
The technique of rapid rate transcranial magnetic stimulation (rTMS) is used to 
evoke intentional and repeated magnetoconvulsive seizures, though it requires 
the use of stimulation parameters practically inaccessible in commercially avail-
able rTMS magnetic stimulators. Magnetic convulsion therapy has been tested 
on monkeys as well as humans. A decisive majority of studies carried out both 
on animals and humans addressed the issue of safety of the MST method and 
confirmed that the side-effects (mostly of a cognitive nature) which occurred 
after magnetic seizures were weaker than those observed after electroconvulsive 
seizures. An analysis of available sources, however, does not confirm any proven 
antidepressant action of the MST technique. No experimental investigations have 
been carried out on animal models of depression. Clinical effectiveness had been 
confirmed in merely a few (perhaps three) patients with depression. The authors 
submit the results of the hitherto conducted studies on MST to critical analysis, 
particularly in the aspect of their antidepressant efficacy. 
InTRoDucTIon
Since 1992, several new, physical techniques 
attributed with certain therapeutic, antidepres-
sant action have been subject to experimental and 
clinical studies (Higgins & George 2009; Lisanby 
2004; Zyss 2007a). These techniques include: tran-
scranial magnetic stimulation TSM (Padeberg et 
al. 2007a), vagus nerve stimulation VNS (Rush 
2003; Eschweiler 2003a), deep brain stimulation 
DBS (Greenberg 2008), transcranial direct cur-
rent stimulation tDCS (Fregni et al. 2006) and 
magnetic seizure/convulsive therapy MST/MCT 
(Lisanby & Peterchev 2007). The first and the last 
of the above mentioned techniques use a strong, 
alternating, impulse magnetic field; the remaining 
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three methods make use of electric current to evoke the 
desired therapeutic changes. The present work deals 
with magnetic seizure/convulsive therapy. The starting 
point to the research into the new MST technique was 
comprised of the following three assumptions:
• high clinical effectiveness of electroconvulsive 
therapy (ECT);
• relatively low therapeutic effectiveness of tran-
scranial magnetic stimulation (TMS);
• specific seizure-inducing potential of the repeti-
tive rapid-rate stimulation rTMS.
Numerous clinical works as well as clinical practice 
testify to the high antidepressant efficiency of electro-
convulsive therapy (Fink 2000; Gábor & László 2005; 
Sienaert & Peuskens 2006). Despite the low number 
of experimental studies and a much higher number of 
clinical investigations which confirm the antidepressant 
effect of transcranial magnetic stimulation (TMS) – its 
actual effectiveness is not particularly high (Loo 2008; 
Padeberg et al. 2007b). An analysis of the effectiveness 
of TMS basically confirms the observations derived 
from much older studies on electroconvulsive therapy; 
namely that a repeated convulsive seizure, specifically 
seizure activity of an appropriate duration (minimum 
20–30 sec) and of a general (and not local) nature is 
a necessary condition to achieve a strong antidepres-
sant effect. Seizures of an inadequate length (abortive) 
or partial seizures do not result in the occurrence of 
an appropriate, satisfactory clinical effect (d’Elia et al. 
1983; Strömgren et al. 1980; Weiner et al. 2001).
Hence, attempts have been made to make intentional 
use of specific seizure-inducing actions of magnetic 
stimulation (rTMS). Seizure activity in EEG or a clini-
cal epileptic seizure is usually recognized as a compli-
cation or an undesirable side-effect application of the 
rTMS technique – particularly those which generate 
magnetic impulses at high frequencies (Huber 2007; 
Wassermann et al. 1996). In turn, rTMS with a low fre-
quency of stimulation is supposed to inhibit convulsive 
activity – up to quenching type action (Joo et al. 20070. 
There have been attempts made to utilize this effect in 
the treatment of drug-resistant epilepsy (Tergau & Wer-
hahn 2007).
The method which consists of the eliciting of sei-
zure activity within the patient’s cortex with the use 
of magnetic stimulation (instead of electric stimula-
tion applied in ECT) has been named magnetic seizure 
therapy (MST), magnetic convulsive therapy (MCT) or 
magnetoictal therapy (MIT).
From a historical standpoint, it is Ollendorf who 
should be recognized as the forerunner of the MST 
technique. In theory published in 1964, he performed 
a mathematical analysis of the possible triggering of 
electroshock with the use of inductive (i.e. magnetic) 
stimulation. However, clinical and experimental studies 
on the MST technique are mostly associated with Sarah 
H. Lisanby from the Institute of Psychiatry in New York.
ExPERIMEnTAl InvEsTIGATIons on 
AnIMAls
Then first experiments with the aim of evoking seizure 
activity in EEG with the use of rTMS stimulation were 
conducted on rats. It remains difficult to explain why 
it has proven impossible to trigger seizure activity with 
magnetic stimulation in this species (even in animals 
which were not under general anesthesia). Moreover, 
it should be noted that in the case of rats – due to the 
much smaller anatomical dimensions of the head (and 
therefore, smaller distance between the head surface 
and the brain) – the parameters of stimulation must 
result in the generation of a much stronger magnetic 
and electric field in the animal’s brain than evoked in, 
for example, a human brain. Nevertheless, it still proved 
ineffective in evoking convulsive activity. An opposing 
explanation, namely the impossibility of evoking an 
adequately strong electric field in the brain of a rat, can 
be found in work by Lisanby and Peterchev (2007).
On the other hand, it has proven possible to evoke 
magnetic shock in the macaques (rhesus) – primate 
genus of monkeys (Lisanby 2004). The results of these 
experiments were first presented at the meeting of the 
Biological Psychiatry Association that took place in 
May 1999. It was two years later that the results of these 
experiments were published in the form of a letter to 
the editor (Lisanby et al. 2001a).
The first experiments in which a standard Super 
Rapid commercial stimulator, manufactured by Mag-
stim (Magstim Company Ltd; using 100% maximal 
output, a frequency of 25 Hz, stimulation time of 10 
sec, impulse width 300 μsec, bipolar course), was used 
proved ineffective. The magnetic field generated with 
the use of a 4cm round coil, which was placed over 
the vertex of the head, could not evoke a seizure in a 
monkey anesthetized with methohexital (Lisanby et al. 
2001a).
The first successful magnetic seizure was evoked 
with the help of a modified Magstim Super Rapid 
magnetic stimulator, which eight power modules (or 
boosters) as opposed to the standard number of four. 
The augmented power supply of the stimulator enabled 
the stimulation frequency to be increased to 40 Hz. The 
parameters of the stimulation amounted to ca. 400% of 
the motor threshold and allowed for the triggering of 
repeated seizures in the monkeys subjected to stimula-
tion. Magnetic stimulation evoked typical tonic-clonic 
seizures lasting ca. 10–15 sec. The mode of general 
anesthesia influenced neither the duration of a seizure 
nor its morphology (Lisanby et al. 2001a).
The duration of a seizure could be influenced by a 
gradual prolongation of the stimulation time with the 
help of the titration method. A typical tonic-clonic sei-
zure could be triggered only with the help of impulses 
amounting to 90% of output power of the stimulator that 
were generated with the frequency of 40 Hz within the 
time of 4–5 sec (Lisanby et al. 1999; Lisanby et al. 2001).
427Neuroendocrinology Letters Vol. 31 No. 4 2010 • Article available online: http://node.nel.edu
Magnetic seizure therapy
In the subsequent years it was Tammy Moscrip, a 
doctoral student in The Laboratory of Magnetic Stimu-
lation of The Brain directed by Lisanby, who studied 
magnetoconvulsive stimulation of monkeys (Moscrip 
2005). For this project, a set of research tests which 
examined cognitive functions in monkeys was devel-
oped. After ECT procedures the monkeys were less pre-
cise and slower – as compared to the animals subjected 
to magnetic stimulation or simulated ECT. In regards to 
their cognitive abilities, the monkeys subjected to mag-
netic convulsion stimulation did not differ from those 
of the control group. On the basis of the results, Moscrip 
concluded that MST stimulation (50Hz, 100% of output 
power, 120 or 240 impulses) is less invasive to cognitive 
functions than ECT (Moscrip 2005; Moscrip et al. 2006).
During the course of their work in 2003, the 
researchers dealing with magnetic convulsion tech-
niques conducted on primates listed the similarities 
and differences between magnetic stimulation MST 
and electroconvulsive therapy (Lisanby et al. 2003a).
Using deep electrodes implanted for a longer period 
of time, Lisanby et al. (2003a) showed that the electric 
field generated in brain structures during MST pro-
cedures was much weaker than that generated during 
ECT. Also, the value of the electrical discharge to the 
head was lower in the magnetic method. The nature of 
the forced current flow in these two techniques shows 
that the current flow in electric stimulation leading to 
electroconvulsive seizure is transverse (the current flow 
is perpendicular to the brain surface) while it is longi-
tudinal (parallel to the brain surface) in the magnetic 
method. The distribution of voltage measurements at 
different points of the brain showed that electric stimu-
lation which triggers electric convulsions propagates 
and reaches distant areas of the hemispheres. When 
stimulation was conducted over the right frontal area, 
excitation reached the contralateral frontal area as 
well as the distant parietooccipital areas and the deep 
structures of the brain. During the process of magnetic 
stimulation, the excitation was both weaker and limited 
to the stimulated area – it was of a local nature. The 
results of these investigations were also presented by 
Lisanby et al. (2003b) during the Second International 
Symposium devoted, among others, to Transcranial 
Magnetic Stimulation TMS, which took place in 2003 
in Göttingen.
Lisanby et al. (2003b) as well as Lisanby herself (2004) 
expressed the opinion that MCT/MST magnetic stimu-
lation facilitated more precise control of spatial propa-
gation of the stimulus in the neural tissue of the brain 
than did electric stimulation ECT. Electroshock causes 
the triggering of generalized seizure activity within the 
entire brain – in the frontal lobes as well as in the hip-
pocampus. On the other hand, seizure activity during a 
magnetic shock is limited mostly to the stimulated area, 
e.g., frontal cortex, and therefore the further it is from 
the stimulated area, the weaker its result due to the 
superficial and spatially limited location. As a result, the 
seizure activity either does not reach the hippocampus 
or reaches it with little intensity – which is theorized 
to result in lesser disturbances of cognitive functions, 
e.g., memory, than those which occur after ECT.
Proof of weaker penetration of magnetic shock to the 
deeper cerebral structures was provided by an experi-
ment, conducted by Morales et al. (2003), in which they 
measured plasma levels of prolactin as an indicator of 
hypothalamic-pituitary axis excitation. While ECT usu-
ally evokes a significant increase in the plasma levels 
of prolactin, magnetic shocks revealed only a slight 
increase in the concentration of this hormone.
As the penetration of the physical stimulus into 
deeper brain structures is weaker in magnetic seizure 
technique than it is in ECT, it should be expected that 
MCT/MST stimulation would have lesser impact on the 
phenomena of hippocampus plasticity like mossy-fiber 
sprouting or neurogenesis than those observed after 
ECT procedures (or electroshocks) in experiments on 
rodents. The above research hypothesis was confirmed 
by subsequent experiments carried out by Lisanby’s 
team (Lisanby et al. 2003c; d).
Lisanby’s team also performed experiments in which 
they tried to explain what structural effect can be 
potentially evoked by MCT/MST stimulation. Twelve 
macaques were subjected to magnetic convulsion pro-
cedures every day for six weeks. Neither MCT/MST nor 
ECT procedures performed on the control group led 
to the manifestation of any symptoms of brain tissue 
damage. However, in the ECT group the GFAP reac-
tion (Anti-Glial Fibrillary Acidic Protein – the marker 
of astrocyte damage) was more intensive (Dwork et al. 
2004).
A serious shortcoming of the studies on MST tech-
nique (both those conducted before 2004 and those 
which followed) is that they lack any research into the 
actual effects of magnetic seizures in the behavioral or 
biochemical models of depression in animals (actually, 
in the later period there have been hardly any publi-
cations related to further experiments on animals). In 
the end, MST was not to be a safer or better tool for 
brain stimulation but a physical technique to evoke a 
biological and clinical antidepressant effect. This situ-
ation seems to resemble certain research experience of 
the first author of this work. What is the importance of 
a given method (here: MCT/MST, in the first author’s 
work: rTMS) being safer in regards to cognitive func-
tions or structural aspects if it does not satisfy (or 
prove) the basic requirement, namely (sufficiently high) 
therapeutic (antidepressant) efficacy (Zyss et al. 2006a).
Moreover, almost identical safety results can also 
be achieved in ECT. The technique involves applying 
lower parameters of the electric current, which would 
not lead to generalized seizure activity but keep it 
locally limited. This effect could be reinforced by the 
application of electrodes placed close to one another on 
the surface of the head. The location and arrangement 
of electrodes in this case would force the current flow to 
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be perpendicular rather than parallel to the head/brain 
surface; the current would not penetrate the deeper 
cerebral structures but would “bend” very quickly, 
mostly in the superficial layers, and flow back between 
the electrodes.
clInIcAl InvEsTIGATIons
Soon after their first publication regarding experimen-
tal investigations, Lisanby et al. (2001b) published a 
work in which they reported conducting the first suc-
cessful magnetic convulsion procedures on a human. 
The MCT/MST stimulation procedure was carried out 
in 2000 on a 20 year old woman, a patient of the Psy-
chiatric Clinic of the University Hospital in Bern, with 
a depressive episode lasting three years. During this 
period, the patient had been subjected to therapies with 
a drug from the SSRI group, two tricyclic antidepres-
sants, two drugs from the MAOI group and several other 
new antidepressants. Also, augmentation with lithium, 
triiodothyronine and methylphenidate was admin-
istered. However, all therapies proved unsuccessful.
The patient was subjected to four MCT/MST trial 
procedures – conducted at the rate of three procedures 
per week. During the procedures the patient herself was 
under general anesthesia – during the first two stimu-
lations she was administered ethomidate while for the 
latter two she received thiopental. Muscle relaxation 
was induced with succinylcholine.
MCT/MST was performed with a modified Mags-
tim Super Rapid magnetic stimulator with eight power 
modules.
Only one stimulation was performed during each 
of the first two procedures; later, two stimulations 
were performed during each procedure. The magnetic 
field was generated by a double cone coil, it was only 
during the second stimulation in the third procedure 
that a butterfly coil was used. Before stimulation the 
coils were cooled so that they could be used longer (in 
2000 no manufacturers of commercial rTMS magnetic 
stimulators offered fluid or air cooled coils). The double 
cone coil was placed on the vertex of the patient’s head 
while the butterfly coil was placed on the head over the 
right dorsolateral prefrontal cortex.
During the majority of stimulations, magnetic 
impulses were generated at a frequency of 40 Hz and at 
100% of the output power of the stimulator, which made 
it possible to achieve ca. 240% of the threshold of motor 
excitation. A single stimulation lasted from 2.0 to 6.3 
sec (which corresponds with the duration of the electric 
impulses generated in ECT). In the third and fourth pro-
cedures, the interval between the two subsequent stim-
ulations lasted 28 seconds and 136 seconds respectively.
Magnetic stimulation with the parameters described 
above led to the triggering of convulsive seizures lasting 
from 30 to 250 seconds (confirmed by the EEG records 
and observation of motor symptoms with the help of the 
cuff technique). The work by Lisanby et al. (2001b) states 
that from the second procedure, the threshold of mag-
netic seizure was determined with the titration method.
The magnetic convulsion procedures themselves 
were well tolerated by the patient and brought about a 
reduction of her score on the Hamilton Rating Scale for 
Depression from the initial 20 to 12 points.
Due to unknown reasons – despite the initiate 
improvement – after the initial four procedures, MST 
was terminated in the patient. Furthermore, a series of 
8 classical unilateral ECT procedures was conducted 
bringing about further improvement (a reduction to 8 
points on the Hamilton scale).
The authors concluded that the experiment con-
firmed the ability to evoke seizure activity with the help 
of magnetic stimulation even in subjects under gen-
eral anesthesia (significantly increasing the excitability 
threshold). The authors posed the thesis that one of the 
advantages of MST would be the possible limitation of 
seizure activity to definite areas of the brain and the 
prevention of the spread of a seizure over the entire area 
of the cortex – and this, while allowing for the occur-
rence of a therapeutic effect, would reduce the risk of 
the occurrence of undesirable side-effects. 
An in-depth analysis of the study, however, does not 
reveal the premises on the basis of which Lisanby et al. 
(2001b) could have drawn the presented conclusions. 
The recording of EEG activity was performed with the 
use of the standard two channels and the location of the 
recording electrodes was standard for ECT procedures 
(frontomastoid placement of electrodes). In regards to 
the registered seizure activity – considering the distant 
location of the recording electrodes – it is possible to 
infer that the seizure was not of a local or focal nature 
but of a generalized one. If no larger number of reg-
istering electrodes is applied, it is impossible to assess 
the qualitative and quantitative parameters of seizure 
activity in different areas of the brain. Moreover, clinical 
examinations of ECT clearly confirm that the efficacy 
of generalized seizures is higher than that of local ones. 
Soon after the above-described clinical experi-
ments first confirmed the possibility of evoking seizure 
activity with the help of magnetic stimulation, further 
studies were carried out on a larger number of patients 
(Lisanby et al. 2001c; 2003e). These were clinical studies 
of the first phase aimed at the assessment of the safety 
of magnetic convulsions – mostly in the area of cogni-
tive functions and bioelectric brain activity. These con-
vulsive therapy studies involved ten patients (3 males 
and 7 females) with a diagnosis of major depression. 
During the first two to four procedures, convulsions 
were elicited by magnetic stimulation. Subsequent 
procedures were classical ECT. Magnetic stimulation 
was performed with the use of a modified Super Rapid 
stimulator with sixteen power modules that allowed 
for stimulation at 100% of initial output power of the 
apparatus for 6.6 sec at a frequency of 60 Hz. Magnetic 
impulses (100 to 400 impulses on the average) were 
generated with the use of three types of coils: (a round 
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coil 8 cm in diameter, a butterfly coil with each winding 
7 cm in diameter, and a double-cone coil with windings 
of 9 and 12 cm in diameter), where the magnetic field 
induction amounted to 2 T. Three locations of the coils 
were examined corresponding with the 10–20 system 
designations: F6, Fz and Cz.
The MCT/MST procedures were better tolerated 
than ECT and caused fewer subjective side-effects. 
After MCT/MST the patients regained full orientation 
faster, retrograde amnesia was weaker and other cogni-
tive functions (short-term memory, learning, fluency) 
were less influenced. The magnetic seizure itself was 
usually shorter than an electric seizure, the amplitude 
of the EEG seizure activity was lesser and the effect of 
post-seizure EEG suppression was also weaker.
The above-discussed works of Lisanby’s team from 
the years 2001 and 2003, however, did not include any 
information regarding the effectiveness of the magnetic 
convulsion procedures which had been conducted. In 
this context the use of the name “magnetic convulsion 
therapy” remains unjustified. It would be much more 
correct to use the term magnetoconvulsive stimulation, 
treatment or procedure.
Furthermore, it is impossible to learn from these 
works why the researchers did not apply another 
method – subjecting a patient exclusively to magnetic 
convulsion procedures. The results discussed above 
carry a methodological error – the differences that 
occurred between the groups need not have regarded 
the comparison between MCT/MST and ECT, they 
might refer to the short-term and long-term effects of 
the whole series of convulsions.
In 2003 a work was published by Kosel et al. (2003) 
documenting the positive clinical effect of MCT/MST 
on a 66 year old female patient who had suffered from 
recurrent depressive disorders since the age of 17. How-
ever, the clinical picture was hardly consistent due to 
additional diagnoses of anorexia nervosa and OCD as 
well as several other somatic disorders. In the period 
directly before getting included in the investigations, the 
patient was treated with several drugs including olanzap-
ine, risperidone and St John’s-wort (Hypericum) extract.
The patient was administered 12 MCT/MST proce-
dures in all (frequency 50 Hz, stimulation time 8 sec, 
100% of maximal output; double cone 13 cm coil placed 
over the vertex).
The patient bore the period of treatment well: she did 
not develop the undesirable side effects typical of ECT 
like headaches, muscle pains or memory disturbances. 
It was only once, during the second session that stimu-
lation failed to trigger seizure activity in the patient.
The original work includes a graphic record of the 
ninth MCT/MST procedure administered to the dis-
cussed patient, yet it was neither demonstrative nor 
highly convincing. For ca. 6–7 seconds EEG activity 
did not, in fact, differ basically in its morphology from 
the bioelectric activity preceding the stimulation. Later, 
two high voltage waves 0.5–1 Hz were registered, which 
could have been artifacts, and it is after these that a 
weakly expressed seizure activity occurred. This activity 
lasted slightly longer than the motor seizure registered 
with a special motion detector on the second channel. 
It was impossible, however, to precisely determine the 
point at which the EEG seizure activity terminated. The 
researchers remarked that the registered EEG activity 
was typical of the magnetic seizure stimulations they 
conducted. This might mean that in some records the 
EEG seizure activity – occurring as a result of MCT/MST 
stimulation – was even weaker or possibly totally absent.
The authors also stated that the duration of tonic-
clonic motions was between 14 and 23 seconds. Thus, 
even if a few seconds more were added (cave: EEG 
seizure activity persists longer than the motor seizure 
observed from without), the information allows the 
assumption that some of the magnetic convulsion pro-
cedures could have been of an abortive nature, i.e., did 
nor exceed the minimum of 30 (or even 20) seconds.
Initially it would be hard to assume that such “weak” 
seizures could result in a statistically significant thera-
peutic effect; in this case an antidepressant effect. Such 
improvement, however, was recognized by Kosel et al. 
(2003). The symptoms of the last depressive episode 
had prevailed in the discussed patient for five years. 
Four weeks (35 days) before she was included in the 
experiment and subjected to MCT/MST the severity 
of depression amounted to 33 points on Hamilton’s (21 
items) Depression Scale and 33 points on Beck’s Scale.
Regretfully, the next assessment of depression sever-
ity did not take place the day before the first mag-
netic stimulation. Due to this, it is not clearly known 
whether the decrease of the intensity of depression in 
the patient that was detected at the second examina-
tion, i.e., after the first week of stimulation, was caused 
mainly or basically by the procedure of magnetic stim-
ulation or evoked by several non-specific factors such 
as, e.g., recruitment and qualification for the clinical 
experiment.
During the series of MCT/MST stimulations 
the intensity of depressive symptoms significantly 
decreased. The results on Beck’s and Hamilton’s Depres-
sion Scales dropped to 11 and 6 points respectively, 
indicating remission.
Neuropsychological examinations performed on the 
patient did not show that magnetic seizures would exert 
significant influence on cognitive functions, or else this 
influence was weaker than that described in studies on 
effects of ECT. In turn, SPECT examination confirmed 
improved blood flow in the area of the frontoparietal 
cortex.
In their final conclusions the authors suggested that 
the MCT/MST technique is a new, potentially effective 
and safe instrument in therapy of drug-resistant depres-
sions, which, in the future, might even replace ECT.
The statement given above may be surprising as 
a far-reaching conclusion drawn in the context of a 
single case observation. Lisanby herself (a participant 
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in the study-publication by Kosel et al. (2003) stated in 
her 2004 paper that the antidepressant effectiveness of 
MCT/MST was still unknown.
In her survey of 2004, Lisanby reported conduct-
ing two-center randomized and double-blind clinical 
investigations aimed at the assessment of the efficacy of 
magnetoconvulsive stimulation (with a stimulation fre-
quency of 50 Hz) in the therapy of depressions. During 
the course of the study, 20 patients were subjected to two 
forms of magnetoconvulsive stimulation – one with the 
use of a non-focal “cap” coil placed above the vertex of 
the head and the other with a double-cone coil located 
above the prefrontal cortex. Although a few years have 
passed since, apart from a conference report of 2003 no 
published results of these investigations could be found 
(Lisanby et al. 2003f).
White et al. (2006) presented the results of the con-
trolled investigations conducted on 20 patients sub-
jected to ECT or MCT/MST. The authors demonstrated 
that after magnetic stimulation, patients required less 
time to regain complete orientation; they also needed 
smaller doses of succinylcholine, but at the same time 
their clinical improvement was weaker (lesser reduc-
tion on Hamilton’s Scale). Also, both of these stimu-
lation methods were reported to have had an unclear 
effect on EEG activity.
Padeberg et al. (2007a) concluded that MCT/MST 
was to bring about less intensive subjective side-effects 
than those occurring after ECT. The patients were 
claimed to faster regain complete orientation and pre-
stimulation attention efficacy; their retrograde amnesia 
was also expected to be weaker.
The results of the latest major clinical works dealing 
with comparison of magnetic seizure stimulation and 
ECT were presented by Kirov et al. (2008). The studies 
were carried out on 11 patients suffering from treat-
ment-resistant major depression and the research was 
not aimed at the assessment of antidepressant efficacy 
but at the speed at which the patients recovered orienta-
tion after the procedure.
It was probably due to the weaker magnetic field gen-
erated by the Magstim Theta stimulator (1.2 T instead 
of 2 T) that the effectiveness of triggering magnetic sei-
zures was worse. Eventually, the seizures were evoked 
in 10 out of the 11 patients. Stimulation performed in 
the area of the vertex resulted in a tonic-clonic seizure 
in ten out of 11 cases. In turn, the same stimulation 
executed above the prefrontal area in its midline was 
effective in 3 out of 7 stimulation procedures. From the 
reported duration of seizure activity (10 to 86 seconds, 
mean – 31.3 sec) it is possible to infer that a large pro-
portion of magnetic stimulation procedures – from the 
perspective of ECT practice – was of an abortive nature. 
The investigations confirmed that the recovery of com-
plete orientation after MCT/MST stimulation occurred 
earlier (after 7 min 12 sec) than after ECT (15 min 
20 sec). After magnetic stimulation the patients felt less 
confused (Kirov et al. 2008).
In their 2007 paper, Lisanby and Peterchev calcu-
lated that up until that time 45 patients with a diagnosis 
of treatment-resistant depression had been subjected to 
magnetic seizure stimulation all over the world. A large 
proportion of these patients took part in investigations 
aimed at the assessment of safety of the MCT/MCT 
method and not of its clinical antidepressant effect.
The latest and – probably – third case description 
of antidepressant efficacy of magnetic stimulation was 
recorded by Kayser et al. in 2009. They reported the 
effective administration of MCT/MST in the course of 
a depressive episode in a patient with Type I Bipolar 
Affective Disorder. Again, a major part of the descrip-
tion was devoted to information regarding the nature 
of convulsive seizures themselves (shorter seizure 
duration, lower amplitude of EEG seizure activity, less 
intensive suppression after a seizure) than to clinical 
description of depression (initial and final intensity of 
symptoms, course of illness and applied treatment).
Apart from the investigations discussed above, in 
recent years several reviews have been issued regard-
ing MCT/MST procedures (Braga & Petrides 2007; 
Carpenter 2006; Dumitriu et al. 2008; Eitan & Lerer 
2006; George 2002; Holtzheimer & Nemeroff 2006a; 
Holtzheimer & Nemeroff 2006b; 2008; Kennedy & Gia-
cobbe 2007; Lisanby 2002; Lisanby et al. 2003g; Schläp-
fer 2007; Tamaoki & Motohashi 2007).
FuRTHER cRITIcAl REMARks 
concERnInG McT/MsT TREATMEnT
Although nearly ten years have passed since the first 
clinical experiment was carried and several further 
publications have been issued, hardly anything suggests 
the possibility or usefulness of more widespread use of 
MCT/MST magnetic seizure stimulation in common 
clinical practice. Commercial magnetic stimulators 
do not guarantee the parameters of stimulation that – 
using magnetic impulses – could evoke seizure activity 
in an intentional and repeatable way (and not accidental 
and occasional one). The 2007 launch of air and liquid 
cooled stimulation coils into the market failed to spur 
significant research into MCT/MST.
At the present moment the main factor that limits 
the generation of impulses with high amplitude and at a 
high rate is the power element, i.e., the stimulator itself. 
However, further investigations may be carried out with 
the use of the cooled coils which, being more resistant to 
heat overload, can withstand longer stimulation, yet, at 
the same time, due to a thicker encapsulation of the coil, 
usually generate a weaker magnetic field. These inves-
tigations might show that rTMS administered at higher 
frequencies than those applied today (> 40–50 Hz) 
would allow for the triggering of seizure activity using 
a lower amplitude of the stimulus. This, in turn, would 
make application of commercial stimulators possible.
Our own model studies (Zyss et al. 2005a;b; 2007b; 
Zyss & Sawicki 2007c) and clinical investigations (Zyss 
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et al. 2006a;b; 2007d) indicate that it is the variable of 
the rate of magnetic stimulation and not that of ampli-
tude, which is more important in achieving a definite 
biological effect. For example, in order to obtain – with 
the use of rTMS – the values of current flow within 
the brain similar to those achieved in ECT, it would be 
necessary to use coils powered with 15–25 kA (usually, 
5-8 kA current power is applied in TMS stimulators). It 
would hardly be possible to execute such a solution (a 
large coil with a power system of appropriate param-
eters) and ensure the patient’s safety at the same time. 
The cost of designing, constructing and testing such a 
stimulator seems enormous.
The use of higher stimulation rates may be an alter-
native to the increase of amplitude of a magnetic field 
induction. In accord with observations made in elec-
trophysiological examinations, these higher rates allow 
for the decrease of the sensitivity threshold of nerve 
cells. This is the way recognized nowadays as poten-
tially capable of triggering seizure activity (Zyss et al. 
2006ba). In an experiment carried out at the beginning 
of 2006, our research team managed to trigger the man-
ifestation of seizure activity in EEG (without the clini-
cal symptoms of a seizure) with the use of a one-minute 
stimulation with a magnetic field of 1.7 T induction 
and frequency of 50 Hz generated by a prototype MS-3 
magnetic stimulator (Zyss et al. 2000a;b).
In the context of the conducted investigations, it 
seems hardly possible to work out simulation param-
eters that would, on one hand, make magnetic stimula-
tion capable of evoking a clinical antidepressant effect 
and, on the other hand, make it safe, i.e., prevent it from 
triggering seizure activity. In a conscious patient – and 
a patient subjected to TMS is usually conscious – the 
latter is a serious undesirable side-effect with definite 
clinical and psychological implications. In turn, the 
intentional triggering of seizures with the help of mag-
netic stimulation implies the necessity of protecting the 
patient with anesthesia, and this makes the possible 
application of TMS even more complicated. 
At the present moment it is presumably only the 
Magstim corporation that possesses technological solu-
tions which allow for research into magnetic convulsion 
treatment. However, neither the older modified Super 
Rapid stimulator with 8 or 16 (instead of 4) power 
modules nor the so-called Theta stimulator are freely 
available on the market (they are available on individ-
ual order). It is hard not to mention here the enormous 
cost of obtaining this kind of equipment, its prototypi-
cal character and the limited area of its practical use. 
The above mentioned factors are chiefly responsible for 
the fact that there are only a few centers in the world 
that can carry out research into MCT/MST – and as an 
experimental method at that.
Moreover, in her object work of 2004 Lisanby admit-
ted that even the MST magnetic stimulator in her 
possession was too weak to be used in clinical inves-
tigations. It is sufficient to generate an impulse whose 
value exceeds the convulsion threshold in monkeys. In 
regards to the ca. 20 patients with depression subjected 
to magnetic stimulation up to 2004, as much as 43% of 
the time the convulsion threshold was achieved by the 
use of the maximum parameters of magnetic stimula-
tion. Thus, if the convulsion threshold had been slightly 
higher in these patients, seizure activity would not have 
been evoked in them.
In the context of the postulated superiority of locally 
evoked seizure activity during MCT/MST stimula-
tion, it is difficult to fully understand the arguments 
of Lisanby (2004) and well as Lisanby and Peterchev 
(2007) when explaining the ineffectiveness of stimu-
lation with the more focused butterfly coil. Effective 
seizure activity could be achieved during magnetic 
stimulation with the non-focused round coil. Double 
cone coils manifested medium effectiveness.
In the same work, Lisanby (2004) wrote that mag-
netic convulsions could not be evoked when the stimu-
lating coil was placed above the prefrontal area; they 
were triggered only when the coil was located over the 
vertex of the head. This situation could be explained 
by the lower sensitivity threshold of the motor cortex 
(located in the area close to the vertex) as compared 
to the prefrontal cortex. However, a clinical problem 
involves the fact that the metabolic disturbances iden-
tified during a depressive episode more frequently 
involve the prefrontal cortex and not the cortex of 
motor areas (Nahas et al. 2003; Stern et al. 2007).
In the case of ECT with the aim of triggering general-
ized seizure activity which also covers metabolically dis-
turbed brain areas, it is not absolutely important where 
the seizure activity is initiated. To diminish the risk of the 
occurrence of cognitive symptoms it is possible to place 
stimulating electrodes over the non-dominant hemi-
sphere. But for the hair, in order to increase the effective-
ness of ECT it would be better to locate the electrodes 
not in the typical frontotemporal areas, but further back 
and higher – closer to the motor cortex area. It would be 
good for this kind of stimulation to choose the points 
determined by Lancaster et al. (1958) or Krzyżowski 
(1991) – mostly applied bilaterally. Due to the shorter 
distance to the motor cortex area and the low sensitivity 
threshold of this area of cortex, it can be expected that 
the current flow parameters and therefore the electric 
load for the entire brain/head necessary to evoke sei-
zure activity would be the lowest as compared to other 
electrode locations. Sufficiently strong seizure activity 
initiated in the area of the premotor cortex would not get 
extinguished there but would spread over the entire brain 
reaching the metabolically disturbed brain structures 
where it will exert its therapeutic influence. Thus, if the 
MCT/MST method can only evoke a weak, local seizure 
activity in a human, mostly in the motor area, and this 
activity cannot spread to other areas of the brain, this fact 
cannot confirm that magnetic convulsions in their pres-
ent form could manifest a significant antidepressant effi-
cacy, as seen in the case of abortive electroconvulsions.
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Another unfavorable premise as observed by Lisanby 
(2004) is the increase of seizure threshold following 
further magnetic convulsion procedures. In monkeys 
this increase was ca. 31% and in humans it amounted 
to 66.7%. This phenomenon is also observed in ECT. 
However, ECT stimulators are usually constructed with 
a significant power (charge or energy) reserve. This 
means that even with the increase of convulsion thresh-
old it is possible to increase the stimulation parameters 
so that in most cases the triggering of seizure activity 
in subsequent stimulations is possible (if necessary, in 
ECT stimulators it is even possible to switch to a wider 
range of stimulating impulse parameters, e.g. “double 
dose/energy”). 
On the other hand, according to Lisanby herself, in 
the case of stimulators used in MCT/MST technique 
(even those modified by custom order) no such power 
reserve is available. Unfortunately, Lisanby (2004) did 
not report how she solved the problem with the patients 
whose sensitivity threshold required the maximum 
parameters even during their first magnetic stimulation 
and increased after the first or subsequent procedures. 
In their case none of the available magnetic stimula-
tors were able to evoke effective magnetic convul-
sions. Lisanby did not state whether such patients were 
excluded from the clinical investigations or whether 
their treatment was continued with the use of ECT.
In the case of ECT there is a certain relationship 
between the power of the electric stimulus and the final 
therapeutic effect. The stronger the stimulus (obvi-
ously, within a certain range – too large electric charges 
would be unfavorable in respect to the increased risk 
of potential side-effects), the longer the seizure activity, 
and its duration is one of the main prognostic param-
eters which highly correlates with the final therapeutic, 
i.e., antidepressant effect (Weiner et al. 1986; Weiner & 
Krystal 1993). Since the magnetic stimulators acces-
sible nowadays make it possible only to achieve con-
vulsion threshold – the relation between stimulation at 
suprathreshold values and the efficacy of MCT/MST is 
impossible to determine.
To illustrate the problems that rTMS technique has 
to cope with, a comparison can be presented. Stimu-
lation in ECT is executed with electric voltage ranges 
from 200 to 400 V with current value not exceeding 1 A 
(Zyss et al. 2007e). At the same time, in order to obtain 
the appropriate magnetic field using the rTMS tech-
nique, the stimulating coil must be powered with volt-
age of 1 000–3 000 V and the current flowing through it 
amounts to 4 000–7 000 A. The current flows in the coil 
winding separated from the patient with merely a few 
millimeters of insulation. The whole system must be safe 
for the patient in regards to electricity, temperature and 
mechanics. The stimulators and coils currently available 
on the market seem to have reached the limits of the 
material and construction potential (Zyss et al. 2007a).
In his work of 2003 Eschweiler reported that the 
system of a magnetic stimulator used in MCT/MST 
techniques is subjected to such current carrying and 
heat load that after a few stimulations the power supply 
modules get damaged (Eschweiler 2003b).
From a technical point of view it is significantly 
easier to control and modify currents of several hun-
dred mA (as in ECT) than those of a few thousand A 
(as it is in magnetic convulsion stimulation). Anti-elec-
trocution protection of the patient and the personnel in 
ECT is much easier than that in rTMS method. An ECT 
stimulator is usually a small, portable electro-medical 
apparatus. rTMS stimulators that can evoke mag-
netic convulsions must be additionally equipped with 
numerous elements (power units, coupling and moni-
toring units, conductors, coils, stands); they are heavy, 
barely portable integrated units, sometimes requiring 
a three-phase power supply whose purchase price is 
several times higher than that of an ECT stimulator. It 
is hard to recognize a medical technique as applicable 
when it requires the use of prototypical equipment that 
is constructed on individual order and owned by 2 or 4 
centers in the world.
The above mentioned Magstim Theta stimulator is 
still a prototypical apparatus and cannot be found in 
the official product line of the corporation. December 
of 2008 MagVenture corporation presented their own 
piece of equipment for evoking magnetic seizures: the 
MagPro MST stimulator. However, no data concerning 
experimental or clinical investigations in which this 
type of stimulator might have been used are available. 
Therefore nothing can be said about the actual effec-
tiveness of the stimulation parameters it offers (mag-
netic field induction up to 2T, stimulation frequency 
ranging from 100 to 250 Hz, stimulation time from 1–6 
sec) (MagVenture A/S).
PosTulATEs AnD REsEARcH 
HyPoTHEsEs
From a cognitive point of view, research into the effec-
tiveness of magnetic stimulation therapy and magnetic 
convulsive therapy (MST/MCT) will probably be con-
tinued (Rowny et al. 2009). The following research steps 
are proposed:
1.  Equipment design research
1.1. Research leading to the construction of mag-
netic stimulators that would enable the genera-
tion of strong magnetic impulses (>2 T); most 
commercial coils for rTMS do not generate a 
sufficiently strong field with frequencies up 
to several dozen Hz (60–90 Hz; these are the 
optimum frequencies used for stimulation of 
the brain in the ECT technique) for a relatively 
long time (several to several dozen seconds; in 
ECT 0.5 to 6 seconds of stimulation initiates 
autostimulation in form of seizure activity; for 
weaker stimulation, namely MST/MCT, the 
time of stimulation should be longer);
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1.2. Construction of effective and safe stimula-
tion coils; it is extremely difficult to combine 
the ability to produce a strong magnetic field 
(which is possible only in small coils which 
allow a highly concentrated magnetic field) 
with the ability to generate and sustain a mag-
netic field for an extended duration and with 
an adequately high frequency (this requires an 
intensive cooling of the coils, preferably with 
liquid); combination of these three properties 
has not yet been achieved to a sufficient extent 
in commercially produced coils.
2. Experiments on animals
2.1. Explanation is required regarding why it has 
not been yet possible to evoke magnetic sei-
zures in rodents, e.g., in rats, for which there 
exist well tested animal models of depression 
[forced swim test (Schechter & Chance 1979), 
chronic mild unpredictable stress (Willner et 
al. 1987)];
2.2. Since magnetic seizures can be evoked in mon-
keys, it is necessary to test the MST/MCT tech-
nique in relation to the models of depression 
developed by McKinley (1977);
3. Clinical studies
3.1. In all studies on MCT/MST it is necessary to 
subject patients with depression undergoing 
treatment not only to evaluation in regards to 
their safety (e.g., the evaluation of their cog-
nitive functions), but also, and primarily, in 
the aspect of the effectiveness of the therapy 
(appropriate clinical tests: MADRAS, HAMA, 
Beck Inventory).
There exist, however, opposing arguments, which 
seem to suggest there is little reason for further studies 
on MST/MCT in the therapy of depressive disorders, 
since the effectiveness of this method can never equal 
the effectiveness of ECT therapy:
1. Equipment design research
1.1. Model testing confirms that the current 
parameters (current density) that exist during 
MST/MCT stimulation (which is only slightly 
stronger than TMS) are at least ten times as 
weak as those which occur during ECT stimu-
lation just before the initiation of seizure activ-
ity (SSAD – self sustained after-discharge). 
Since (for the coreless air coils) there exists 
linear interdependence between the current 
generated in the MST/MCT stimulator and 
the generated magnetic field and, additionally, 
the currents generated in the tissue, it would 
be insufficient to generate magnetic fields 
amounting to 3–4 T; to obtain the conditions 
prevalent in a human head during an applica-
tion of ECT technique it would be necessary 
to generate a field of 10–15 T (Nadeem et al. 
2003; Sekino & Ueno 2004; Zyss 2009). In the 
case of medical stimulators, the generation 
of impulsive magnetic fields is extremely dif-
ficult (much stronger magnetic fields can be 
obtained in engineering, but the technologies 
applied there, e.g. Bitter magnets (Bitter 1961), 
can not be applied in MST/MCT technique. 
Moreover, the safety aspects of the application 
of such strong fields are unknown.
 Since the above consideration referred to 
generalized seizure activity – recognized as 
therapeutically effective in the case of ECT – 
obtaining focal (locally limited) seizure activity 
would probably require application of slightly 
weaker fields.
1.2. As it has been shown above, the generation of 
such strong fields would require special coils 
powered with currents of amplitudes reaching 
several thousand amperes. The construction of 
a stimulating coil that could be safely applied 
in clinical conditions, i.e., close to the patient’s 
head, appears to be impossible, due to inherent 
problems with mechanical, electric and ther-
mal safety (Davey & Riehl 2005; Ruohonen & 
Ilmoniemi 2005).
2. Experiments on animals
2.1. The differences in size between a typical 
stimulating coil and the head of a laboratory 
animal, such as a rat, cause the electric con-
ditions which occur in the head of an animal 
during MST/MCT stimulation to be differ-
ent than those which occur in a human head 
during a similar stimulation procedure (due to 
the thickness of the surface layers the magnetic 
field as well as the secondary induced currents 
in an animal must be stronger than those in a 
human); furthermore, the effective stimulation 
area (otherwise known as the hot point – the 
area closest to the internal radius of the coil) 
must cover the entire animal brain and not a 
few square centimeters – as it does in the case 
of a human. Thus, if seizure activity can be 
evoked in rats for definite parameters, it will 
probably be of a generalized nature and not of 
local nature like in humans or monkeys. There-
fore, in its mechanism it will not differ from 
the generalized seizure activity evoked during 
ECT procedures and this suggests that it will 
not have the “advantages” of MST/MCT like 
higher safety in regards to cognitive processes
2.2. The availability (as well as costs and bioethical 
aspects) of experiments on primates signifi-
cantly reduces the possibilities of verification 
regarding how effective MST/MCT actually is 
in the monkey model of depression.
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3. Clinical studies:
3.1. The days of studies on ECT with simulated 
(sham) electric stimulation as a true placebo 
are long gone (Lambourn & Gill 1978; Free-
man 1978). Both the ethical aspects (the atti-
tudes of the local bioethics boards included) 
and people’s prejudices towards all kinds of 
electromagnetic stimulation of the head area 
may become a significant obstacle for further 
clinical studies(Rasmussen 2009; Ross 2006).
3.2. Clinical studies on ECT show that only gener-
alized seizures lasting at least 20–30 seconds 
have an antidepressant effect (Beyer et al. 
1998; Sackeim et al. 1991). Focal and abor-
tive seizures as well as prematurely terminated 
ones are ineffective. Thus, it is unreasonable 
to expect that the focal seizure activity which 
occurs during MST/MCT should cause any 
significant clinical improvement in patients 
suffering from depression. 
3.3. Since MST/MCT is, it is widely assumed, less 
effective than ECT and nearly as laborious of a 
technique (the necessity of applying anesthet-
ics, evoking of seizure activity), there are no 
valid reasons to grant preference to this tech-
nique over ECT. The above mentioned aspect 
of safety seems to be of little importance in the 
face of the overall lower effectiveness of MST/
MCT. The decision concerning the patient’s 
qualification for ECT is usually made in the 
case of highly intense mental disturbances 
(including severe depression, suicidal ten-
dencies, accompanying psychotic symptoms, 
drug resistance). In these situations it would 
be senseless and unethical to offer a patient 
a method that is less effective. A situation in 
which the administration of ECT would be 
ineffective while the use of MST/MCT would 
prove effective seems highly improbable.
3.4. Perhaps the effectiveness of MST/MCT (as well 
as that of the even weaker technique of TMS) 
could be improved if more specifically focused 
magnetic stimulation was applied. It would be 
necessary to apply functional neuroimaging 
(e.g. fMRI, SPECT) to identify the superficially 
located structures with a disturbed metabo-
lism (deep locations are hardly accessible for 
magnetic stimulation) conditioning the basic 
disorder (depression). Presumably, magnetic 
stimulation precisely focused on this area with 
the help of neuronavigation techniques could 
allow for the elimination of the metabolic dys-
function (Dell’osso & Altamura 2009; Lefau-
cheur et al. 2007; Schutter & van Honk 2005). 
This might be one of the possible explanations 
for the success of the clinical experiment car-
ried out by Mayberg et al. in 2005. The experi-
ment consisted of implanting electrodes into 
Broadmann area 25, which was earlier iden-
tified as metabolically hyperactive and then 
subjected to deep brain stimulation (DBS). By 
stimulating the area identified as the potential 
substrate of depression in selected patients, it 
was possible to achieve a therapeutic effect by 
way of non-convulsive stimulation.
 Most studies in which TMS was applied to the 
left dorsolateral prefrontal cortex – the region 
recognized a priori as the “seat of depression” 
and a good target for magnetic stimulation – 
caused magnetic stimulation to be applied to 
an undisturbed area in numerous patients. Few 
studies on the improvement of the effective-
ness of TMS in the treatment of depression, 
which would describe or use the previously 
mentioned and complicated instrumentation, 
have been published so far. The lower effective-
ness of the TMS technique could be explained, 
among other theories, by magnetic stimulation 
administered “at random”, i.e., in the area that 
potentially participates in the etiopathogenesis 
of depression, but not in every patient. Since 
MST/MCT evokes only partial and not gener-
alized seizure activity, the above remarks con-
cerning TMS also apply to this technique to a 
large extent.
 The outlined suggestions regarding the 
improvement of the effectiveness of MST/MCT 
make this method either user unfriendly (if all 
additional supporting techniques be applied) 
or ineffective (without these techniques). To 
compare: the generalized seizure activity that 
occurs during ECT and leads to the excitation 
of the entire neuronal network of the brain, 
including all neurotransmitter systems, allows 
ECT to be applied “at random”, i.e., without 
previous neuroimaging diagnostics searching 
for the source of depression, and without the 
necessity of placing stimulating electrodes in 
specific areas of the head.
conclusIons
The authors of this work perceive the potential clinical 
benefits of magnetic convulsions as rather illusory. The 
prospect of the diminishment of undesirable side effects 
in the area of cognitive disturbances by way of MCT/
MST stimulation as compared to those which occur 
after ECT does not seem well grounded. Even today, an 
appropriate selection of parameters in ECT procedures 
can to a large extent influence the severity of the cogni-
tive side effects. The lower current parameters (ampli-
tude, frequency, width, stimulation duration, charge or 
energy), which result in shorter seizures (30–40  sec-
onds), are safer in regards to cognitive functions than 
parameters which evoke long seizure activity (1–2 min-
utes). Less frequent application of ECT procedures 
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would be more favorable for cognitive functions than 
more frequent one (2 versus 3 procedures per week). 
Also, the effect of ECT procedures conducted unilater-
ally, i.e., sparingly on the dominant hemisphere, is also 
a well known and described phenomenon (Hese 2007).
All comparisons regarding difference in safety 
between ECT and MCT/MST, however, are of second-
ary importance if all our knowledge regarding actual 
antidepressant efficacy is based on three (incomplete 
at that) case reports and there are neither any broader, 
controlled, randomized and double-blind performed 
comparative studies nor any larger number of pilot 
studies performed on small groups of patients. In 2007 
Padeberg et al. (2007a) assessed the number of patients 
subjected to magnetic seizure stimulation procedures 
all over the world as 40 and, as has already been men-
tioned, the investigations were concerned mostly with 
the aspect of safety and not that of clinical efficacy. 
Since MCT/MST technique still includes “convul-
sions” or “seizures” in its name, it would be difficult to 
presume that magnetic technique could evoke lesser 
worries and objections in a potential patient or in the 
general public than those referring to electroconvulsive 
treatment.
It appears that in the nearest future, studies on 
magnetic convulsions will still be of an investigational 
rather than an applied nature.
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